3649 studies found for:    "Depressive Disorder" [DISEASE]
Show Display Options
RSS Create an RSS feed from your search for:
"Depressive Disorder" [DISEASE]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety and Efficacy Study in Patients With Major Depressive Disorder
Conditions: Depressive Disorder;   Major Depressive Disorder (MDD);   Major Depressive Episode
Interventions: Drug: GSK163090 Tablets;   Drug: GSK163090 Placebo Tablets
2 Active, not recruiting Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Intervention: Drug: OPC-34712 + ADT
3 Recruiting A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: Brexpiprazole;   Drug: Seroquel XR;   Drug: Placebo
4 Completed Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: OPC-34712 + ADT;   Drug: Placebo + ADT
5 Completed Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: OPC-34712 + ADT;   Drug: Placebo + ADT
6 Recruiting Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: Placebo + ADT;   Drug: Brexpiprazole +ADT
7 Recruiting Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
Conditions: Major Depressive Disorder;   Major Depressive Disorder, Recurrent, Unspecified;   Major Depressive Disorder, Single Episode, Unspecified
Interventions: Drug: Escitalopram oxalate;   Device: transcranial direct current stimulation
8 Withdrawn Brain Imaging, Genetics and Treatment for Major Depression
Conditions: Depressive Disorder;   Depressive Disorder, Major;   Depression
Intervention: Other: Citalopram
9 Completed Study Of GW679769 In Major Depressive Disorder
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
10 Not yet recruiting Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)
Conditions: Major Depressive Disorder;   Major Depressive Episode
Intervention: Drug: Venlafaxine  extended release
11 Terminated Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
Conditions: Hepatitis C;   Depressive Disorder, Major;   Depressive Disorder;   Depression;   HIV Infections
Interventions: Behavioral: Hepatitis C educational support groups;   Behavioral: Cognitive Behavioral Therapy skills based group sessions
12 Completed Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
13 Terminated Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
Conditions: Major Depressive Disorder;   Major Depressive Disorder w/ Psychotic Features;   Metabolic Syndrome
Intervention:
14 Not yet recruiting Study to Treat Major Depressive Disorder (MDD) With a New Medication
Conditions: Major Depressive Disorder;   Depression
Intervention: Drug: ezogabine
15 Completed Evaluating Brain Responses to Facial Expressions in Major Depressive Disorder
Conditions: Current Major Depressive Disorder;   Healthy;   Remitted Major Depressive Disorder
Intervention:
16 Completed N-methylglycine (Sarcosine) Treatment for Depression
Conditions: Major Depressive Disorder;   Depression;   Major Depression
Interventions: Drug: citalopram;   Drug: sarcosine
17 Terminated Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder
Conditions: Depression;   Depressive Disorder
Interventions: Device: Cortical Stimulation;   Device: Sham
18 Completed A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
Conditions: Depressive Disorder;   Depressive Disorder, Major;   Depression
Intervention: Drug: risperidone
19 Unknown  Using Neuroimaging to Investigate Major Depressive Disorder
Conditions: Major Depressive Disorder;   Depression;   Anxiety
Intervention:
20 Withdrawn Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder
Conditions: Depression;   Major Depressive Disorder
Intervention: Biological: RO4995819

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years